Warfarin pharmacogenetics: challenges and opportunities for clinical translation.
作者信息
Limdi Nita A
机构信息
Department of Neurology, University of Alabama at Birmingham Birmingham, AL, USA ; Department of Epidemiology, University of Alabama at Birmingham Birmingham, AL, USA.
出版信息
Front Pharmacol. 2012 Oct 17;3:183. doi: 10.3389/fphar.2012.00183. eCollection 2012.
Abstract
摘要
相似文献
1
Warfarin pharmacogenetics: challenges and opportunities for clinical translation.
Front Pharmacol. 2012 Oct 17;3:183. doi: 10.3389/fphar.2012.00183. eCollection 2012.
2
Use of pharmacogenetics to guide warfarin therapy.
Drugs Today (Barc). 2004 Mar;40(3):247-57. doi: 10.1358/dot.2004.40.3.820088.
3
Pharmacogenetics in Cardiovascular Medicine.
Curr Genet Med Rep. 2016 Sep;4(3):119-129. doi: 10.1007/s40142-016-0096-z. Epub 2016 Jun 16.
4
[Application of warfarin pharmacogenetics].
Vnitr Lek. 2009 Jun;55(6):565-9.
5
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Clin Pharmacol Ther. 2011 Nov;90(5):701-6. doi: 10.1038/clpt.2011.186. Epub 2011 Sep 28.
6
Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Clin Pharmacol Ther. 2014 Jul;96(1):22-4. doi: 10.1038/clpt.2014.78.
7
Pharmacogenetics of warfarin.
Annu Rev Med. 2010;61:63-75. doi: 10.1146/annurev.med.070808.170037.
8
Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.
J Mol Diagn. 2010 May;12(3):283-91. doi: 10.2353/jmoldx.2010.090110. Epub 2010 Mar 12.
9
Warfarin pharmacogenetics: does more accurate dosing benefit patients?
Semin Thromb Hemost. 2012 Oct;38(7):661-6. doi: 10.1055/s-0032-1326789. Epub 2012 Oct 9.
10
Warfarin pharmacogenetics.
Pharmacotherapy. 2008 Sep;28(9):1084-97. doi: 10.1592/phco.28.9.1084.
引用本文的文献
1
Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study.
Biomedicines. 2023 Aug 19;11(8):2308. doi: 10.3390/biomedicines11082308.
2
Control-Relevant Adaptive Personalized Modeling From Limited Clinical Data for Precise Warfarin Management.
IEEE Open J Eng Med Biol. 2023 Jan 26;3:242-251. doi: 10.1109/OJEMB.2023.3240072. eCollection 2022.
3
Hypermethylation of brain natriuretic peptide gene is associated with the risk of rheumatic heart disease.
Biosci Rep. 2017 Jan 17;37(1). doi: 10.1042/BSR20160408. Print 2017 Feb 28.
4
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
PLoS One. 2016 Sep 16;11(9):e0162866. doi: 10.1371/journal.pone.0162866. eCollection 2016.
5
Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
Curr Opin Cardiol. 2013 May;28(3):305-14. doi: 10.1097/HCO.0b013e32835f0bbc.
本文引用的文献
1
The future of warfarin pharmacogenetics in under-represented minority groups.
Future Cardiol. 2012 Jul;8(4):563-76. doi: 10.2217/fca.12.31.
2
Warfarin pharmacogenetics: a rising tide for its clinical value.
Circulation. 2012 Apr 24;125(16):1964-6. doi: 10.1161/CIRCULATIONAHA.112.100628. Epub 2012 Mar 19.
3
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Circulation. 2012 Apr 24;125(16):1997-2005. doi: 10.1161/CIRCULATIONAHA.111.070920. Epub 2012 Mar 19.
4
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292.
5
New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e120S-e151S. doi: 10.1378/chest.11-2294.
6
Novel oral anticoagulants and their role in clinical practice.
Pharmacotherapy. 2011 Dec;31(12):1175-91. doi: 10.1592/phco.31.12.1175.
7
Emergency hospitalizations for adverse drug events in older Americans.
N Engl J Med. 2011 Nov 24;365(21):2002-12. doi: 10.1056/NEJMsa1103053.
8
Novel anticoagulants for atrial fibrillation: a critical appraisal.
Angiology. 2012 Apr;63(3):164-70. doi: 10.1177/0003319711422808. Epub 2011 Oct 17.
9
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7.
10
Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective.
Thromb J. 2011 Jul 27;9:12. doi: 10.1186/1477-9560-9-12.
Zotero 插件